SARS-CoV-2

Understanding why COVID-19 tends to strike the old but spare the young could inform how to prioritize limited COVID-19 vaccines.

Four newly discovered SARS-CoV-2 peptides not only promise to make COVID-19 tests cheaper and more specific, but may also reveal disease severity.

In a classic case of double trouble, the binding of SARS-CoV-2’s spike protein to bacterial lipopolysaccharide supercharges inflammation in COVID-19 patients.

These novel immune signatures identify patients most at risk for developing severe COVID-19 symptoms.

Lockdown measures not only reduced the number of COVID-19 cases but also resulted in a temporary improvement in air quality, study finds.

Using flow cytometry, researchers have developed a sensitive and specific test for COVID-19 that can identify asymptomatic carriers.

Plant-based ionizers are surprisingly effective at removing aerosols and could play an important role in preventing COVID-19 transmission.

A multifaceted study by the Singapore 2019 Novel Coronavirus Outbreak Research team is filling in some of the gaps left in the urgent quest to understand COVID-19 infection.

A*STAR researchers have developed a point-of-care rapid antibody test kit that can detect antibodies produced in response to SARS-CoV-2 infection in just fifteen minutes.

By eliminating bottlenecks and automating manual processes, the RESOLUTE test kit and RAVE system co-developed by A*STAR scientists will help give COVID-19 testing a much-needed boost.

A*STAR researchers use digital drug simulators to predict the efficacies of repurposed antivirals for treating COVID-19.

This ‘smart mask’ designed by A*STAR researchers may reduce the risk of infection in healthcare workers by enabling remote, real-time monitoring of patients’ symptoms.